Chargement en cours...
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
Cancer patients have been treated with various types of therapies, including conventional strategies like chemo‐, radio‐, and targeted therapy, as well as immunotherapy like checkpoint inhibitors, vaccine and cell therapy etc. Among the therapeutic alternatives, T‐cell therapy like CAR‐T (Chimeric A...
Enregistré dans:
| Publié dans: | Cancer Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6675705/ https://ncbi.nlm.nih.gov/pubmed/31199589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2257 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|